IPSEN: Description of the Regulatory Framework of the Share Repurchase Program Proposed by the Board of Directors to Be Approved at the Combined Shareholders' Meeting on 24 May 2022 (17th Resolution)

Regulatory News: IPSEN (Paris:IPN) (OTC Pink:IPSEY): In accordance with the provisions of Article L. 22-10-62 et seq. of the French Commercial Code, the European Regulation (EU) No 596/2014 of

Related Keywords

China ,Saclay ,France General ,France ,Shanghai ,Cambridge ,Cambridgeshire ,United Kingdom ,United States ,Paris ,French ,American ,Georges Gorse ,Gwenan White ,Ioana Piscociu ,Global Communications ,Public Affairs ,European Parliament ,Company Or Group ,Regulatory News ,French Commercial Code ,European Regulation ,Delegated Regulation ,General Regulation ,French Autorit ,Des March ,Combined Shareholder Meeting ,Shareholder Meeting ,Combined Shareholder ,Extraordinary Shareholder ,Rare Disease ,With Specialty Care ,Consumer Healthcare ,Sponsored Leveli American Depositary Receipt ,Billancourt France ,Investor Relations ,Relations Manager ,Vice President ,Communications Director ,Lipsen ,Description ,Egulatory ,Framework ,Phare ,Epurchase ,Program ,Roposed ,Board ,Directors ,Approved ,Combined ,Shareholders ,Meeting ,022 ,7th ,Resolution ,